Loading company…
Navitor Pharmaceuticals, Inc., based in Cambridge, US, develops treatments for metabolic diseases such as obesity and diabetes.
Founded in 2010 and headquartered in Cambridge, US, Navitor Pharmaceuticals, Inc. develops proprietary compounds that modulate cellular metabolism to treat metabolic disorders, including obesity and diabetes. It earns revenue through licensing agreements with milestone payments and royalties, alongside B2B sales. The company has completed 5 deals, and its most recent, in December 2018, raised USD 11.25 mn in venture funding. Jun Hu is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in